Abstract:Background: Basal ganglia and thalamic arteriovenous malformations (AVMs) represent a special subset of malformations. Due to the involvement of vital brain structures and the specifically fine and delicate angioarchitecture of these lesions, it presents unique therapeutic challenges and technical difficulties that require thorough treatment planning, individualized treatment strategies, and advanced techniques for good clinical outcome. Method: In this study, we presented a series of ruptured basal ganglia and thalamic AVMs embolized via a transarterial, transvenous or combined approach. Herein, we summarized our treatment experience and clinical outcomes to further evaluate the effectiveness and safety of endovascular embolization for these AVMs as well as the indications, therapy strategies, and techniques of embolization procedures. Results: Twelve patients with basal ganglia and thalamus AVMs were included in the study. Their average age was 23.83 ± 16.51 years (range, 4–57 years) with a female predominance of 67% at presentation. The AVMs were located in the thalamus in 3 (25%) patients, in the basal ganglia in 3 (25%) patients, and in both sites of the brain in 6 (50%) patients. There were 5 AVMs located on the left side and 7 on the right. The mean nidus diameter was 3.32 ± 1.43 cm (range 1.3–6.1 cm). According to the Spetzler-Martin grading classification, 4 (33.3%) brain AVMs were Grade III, 7 (58.3%) were Grade IV, and 1 (8.3%) was Grade V. All of them presented with bleeding at admission: four of these patients presented with an intracerebral hemorrhage (ICH), 8 ICH in combination with intraventricular hemorrhage (IVH), and no patient with subarachnoid hemorrhage (SAH). Among these patients treated with endovascular embolization, 7 patients were treated by the transarterial approach, 4 patients transvenous approach, and 1 patient underwent the combined approach. A single embolization procedure was performed in 6 patients (50%) and the other 6 cases (50%) were treated in a staged manner with up to three procedures. Procedure-related complications occurred only in two patient (16.7%). Complete AVM obliteration was obtained in 7 patients (58.3%), and partial obliteration was in 4 patients (33.3%). Overall, good or excellent outcomes were obtained in 7 patients (58.3%), and poor functional outcome was observed in 5 patients (41.7%) at the last follow-up. All survived patients achieved anatomic stabilization and there was no postoperative bleeding or recurrence in the follow-up. Conclusion: The management of the basal ganglia and thalamic AVMs is a great challenge, which needs multimodal individualized treatment to improve the chances of radiographic cure and good outcomes. Endovascular therapy is safe and effective in the treatment of cerebral AVMs particularly for deep-seated AVMs such as the basal ganglia and thalamus. Our results demonstrate a high rate of anatomic obliteration with an acceptable rate of complications in the endovascular treatment of these vasculopathies via a transarterial approach or a transvenous approach.

Facial Arteriovenous Malformation Embolized Using n-Butyl-2 Cyanoacrylate and Contrast Stasis Rather Than Tantalum Powder with Double Flow Arrest to Prevent Skin Discoloration: A Technical Note

Relationship of Bleeding Complications and Impairment of Draining Veins after Α-N-butyl Cyanoacrylate Embolization of Brain Arteriovenous Malformations

Treatment of high grade cerebral anteriovenous malformations with Onyx embolic agent

Hybrid Surgery for an Arteriovenous Malformation Fed by an Accessory Middle Cerebral Artery and Drained by a Developmental Venous Anomaly: A Case Report and Literature Review

Excision of arteriovenous malformation in an emergency situation - A case report

Endovascular Treatment of Scalp Arteriovenous Fistula: Transvenous Onyx Embolization with Balloon Occlusion

Microsurgical Excision Combined with Preoperational Endovascular Embolization in Treatment of Cerebral Arteriovenous Malformation

[Efficacy of Suture Ligation Combined with Super-Wet Tumescent Techniques in Resection of Peripheral Arteriovenous Malformations of Head and Neck].

En bloc resection of intraosseous arteriovenous malformation (AVM) in the maxilla and deformed bone following embolization and sclerotherapy

Management of Giant Type II Arteriovenous Malformation of the Neck With Heart Failure in a Pediatric Patient With Coil and NLE Embolization: A Case Report

Large arteriovenous malformations of the face: aesthetic results with recurrence control

Intraosseous embolotherapy of central arteriovenous malformations in the jaw: long-term experience with 8 cases.

Transvenous embolization of brain arteriovenous malformations: a review of techniques, indications, and outcomes.

Salvage treatment of hemorrhagic arteriovenous malformations in jaws

Clinical Analysis Of 50 Cases Of Bavm Embolization With Onyx, A Novel Liquid Embolic Agent

Case report: Endovascular treatment of two scalp arteriovenous malformation cases via direct percutaneous catheterization: A case series

[Clinical Experience of 70 Cases of Cerebral Arteriovenous Malformations Embolization with Onyx, a Novel Liquid Embolic Agent].

Results of Endovascular-First Approach for Treatment of Scalp Arteriovenous Malformations and the Effect of Simplified Angiographic Classification in Therapeutic Decision-Making and Outcomes

High-Flow Arteriovenous Malformations: Treatment Using a Venous Approach

Endovascular transvenous treatment for superficial intracranial arteriovenous malformations

Endovascular embolization for basal ganglia and thalamic arteriovenous malformations